Copyright © 2013 David J. Levinthal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background. Multiple sclerosis (MS) patients often suffer from gastrointestinal (GI) symptoms. However, the full extent and prevalence of such symptoms are not clearly established. Thus, we sought to define the prevalence of GI symptoms and syndromes in those with MS. Methods. 218 MS patients completed self-reported demographic and clinical data questionnaires as well as several standardized surveys probing MS severity and GI health. Results. Nearly two thirds (65.6%) of patients endorse...
Full list of author information is available at the end of the articleBackground Gastrointestinal dy...
Contains fulltext : 70215.pdf (publisher's version ) (Closed access)The phenotype ...
OBJECTIVES: To determine whether gut focused behavioural treatment (biofeedback) is a useful therapy...
Introduction: Bowel dysfunction (BD) is reported as a common and disabling symptom in multiple scler...
Background: As new disease-modifying therapies emerge a better knowledge of the risk of comorbid dis...
Introduction: Bowel dysfunction (BD) is reported as a common and disabling symptom in multiple scler...
Introduction: Multiple sclerosis (MS) refers to chronic inflammation of the central nervous system i...
OBJECTIVE: Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS) wi...
Background Bowel and bladder problems affect more than 50% of people with Multiple Sclerosis (MS). T...
INTRODUCTION: Delayed-release dimethyl fumarate (DMF) is an effective treatment for multiple scleros...
INTRODUCTION: Delayed-release dimethyl fumarate (DMF) is an effective treatment for multiple scleros...
Background: Around 50% of people with multiple sclerosis (MS) experience neurogenic bowel dysfuncti...
Background: Gastrointestinal (GI) events are common adverse events (AEs) associated with delayed-rel...
BackgroundBowel and bladder problems affect more than 50% of people with Multiple Sclerosis (MS). Th...
Bowel and bladder symptoms are highly prevalent in patients with multiple sclerosis (MS). Bladder dy...
Full list of author information is available at the end of the articleBackground Gastrointestinal dy...
Contains fulltext : 70215.pdf (publisher's version ) (Closed access)The phenotype ...
OBJECTIVES: To determine whether gut focused behavioural treatment (biofeedback) is a useful therapy...
Introduction: Bowel dysfunction (BD) is reported as a common and disabling symptom in multiple scler...
Background: As new disease-modifying therapies emerge a better knowledge of the risk of comorbid dis...
Introduction: Bowel dysfunction (BD) is reported as a common and disabling symptom in multiple scler...
Introduction: Multiple sclerosis (MS) refers to chronic inflammation of the central nervous system i...
OBJECTIVE: Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS) wi...
Background Bowel and bladder problems affect more than 50% of people with Multiple Sclerosis (MS). T...
INTRODUCTION: Delayed-release dimethyl fumarate (DMF) is an effective treatment for multiple scleros...
INTRODUCTION: Delayed-release dimethyl fumarate (DMF) is an effective treatment for multiple scleros...
Background: Around 50% of people with multiple sclerosis (MS) experience neurogenic bowel dysfuncti...
Background: Gastrointestinal (GI) events are common adverse events (AEs) associated with delayed-rel...
BackgroundBowel and bladder problems affect more than 50% of people with Multiple Sclerosis (MS). Th...
Bowel and bladder symptoms are highly prevalent in patients with multiple sclerosis (MS). Bladder dy...
Full list of author information is available at the end of the articleBackground Gastrointestinal dy...
Contains fulltext : 70215.pdf (publisher's version ) (Closed access)The phenotype ...
OBJECTIVES: To determine whether gut focused behavioural treatment (biofeedback) is a useful therapy...